Why should you subscribe to the OracleBio newsletter?
- Cutting-Edge Insights: Stay informed with the latest advancements and trends in Digital Pathology, helping you make informed decisions and stay ahead in R&D.
- Expert Analysis: Gain access to expert analysis and interpretations of complex image data, enhancing your understanding of cellular phenotyping and its applications in personalized medicine.
- Company News & Service Updates: Interested in what we do? Follow our journey as the leaders within our field, be the first to hear about our growth plans, latest service offerings, and much more.
By subscribing, you are consenting to OracleBio processing your data. For more information about the processing of your personal information and your rights, please review our Privacy Policy.
You may also be interested in these Blogs & Insights:
OracleBio adds HALO AI Quantitative Digital Pathology capabilities to support Clinical R&D Data Generation to a Regulatory Standard
⚡ Article Synopsis: In this latest article, our GCP team talks about the exciting next phase of our Good Clinical Practice services, which have now launched. Expect to learn more about the client benefits. the process of analysing histology images to a regulatory...
Staining and Morphology Factors that can impact accurate AI-driven Nuclear Segmentation
⚡ Article Synopsis: In this article, OracleBio's Chief Scientific Officer, Lorcan Sherry, discusses the intricacies of AI-driven nuclear segmentation and the crucial factors that influence its accuracy in detecting and segmenting nuclei in tissues and cells.Over the...
Confirming AI Decisions: Utilising Indica Labs HALO v3.5 Validation to Strengthen OracleBio’s Classifier Validation Workflow
⚡ Article Synopsis: In this article, OracleBio Image Analysis Scientist, Caitlin Rutherford, highlights how Indica Labs HALO v3.5 validation workflow aids us in streamlining our internal algorithm validation process and explains how we would utilise this workflow in a...
